providing medical information relating to the identification in a patient of genetic variations affecting drug action and the development of pharmaceutical preparations whose mechanism of action is related to the said genetic variation in the treatment of cancer, proliferative diseases, inflammatory diseases, neurological diseases, or cardiovascular diseases

diagnostic preparations used to identify in a patient a genetic variation affecting drug action; pharmaceutical preparations for the treatment of cancer, proliferative diseases, inflammatory diseases, or cardiovascular diseases whose effect is related to the said genetic variation

providing medical information relating to the identification in a patient of genetic variations affecting drug action and the development of pharmaceutical preparations whose mechanism of action is related to the said genetic variation in the treatment of cancer, proliferative diseases, inflammatory diseases, neurological diseases, or cardiovascular diseases

diagnostic preparations used to identify in a patient a genetic variation affecting drug action; pharmaceutical preparations for the treatment of cancer, proliferative diseases, inflammatory diseases, or cardiovascular diseases whose effect is related to the said genetic variation

providing medical information relating to the identification in a patient of genetic variations affecting drug action and the development of pharmaceutical preparations whose mechanism of action is related to the said genetic variation in the treatment of cancer, proliferative diseases, inflammatory diseases, neurological diseases,or cardiovascular diseases

Medical diagnostic preparations used to identify in a patient a genetic variation affecting drug action; pharmaceutical preparations for the treatment of cancer, proliferative diseases, inflammatory diseases, or cardiovascular diseases whose effect is related to the said genetic variation

providing medical information relating to the identification in a patient of genetic variations affecting the safety, toxicity, or efficacy of drugs and the development of pharmaceutical preparations whose mechanism of action is related to said genetic variations in the management and treatment of diseases, disorders, or dysfunctions

diagnostic preparations used to identify in a patient a genetic variation affecting drug action; pharmaceutical preparations for the treatment of cancer, proliferative diseases, inflammatory diseases, or cardiovascular diseases whose effect is related to the said genetic variation

providing medical information relating to the identification in a patient of genetic variations affecting the safety, toxicity, or efficacy of drugs and the development of pharmaceutical preparations whose mechanism of action is related to said genetic variations in the management and treatment of diseases, disorders, or dysfunctions